Regeneron Pharmaceuticals announced on Monday that it will acquire "substantially all" of genetic testing company 23andMe's assets. The pharmaceutical company said it won the court-supervised auction ...

At a court hearing in St. Louis, Mo. yesterday (June 4), 23andMe’s attorney inadvertently revealed that Wojcicki’s post-auction proposal had reached $305 million. Wojcicki, who resigned as 23andMe’s ...

Every time Nora publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from Business ...

Add Yahoo as a preferred source to see more of our stories on Google. Anne Wojcicki, the former chief executive of 23andMe, speaks at UC San Francisco's Genentech Hall in 2013. (Jeff Chiu / Associated ...

Claims are now open for nearly 7 million people who were affected by 23andMe's data breach in 2023, with the beleaguered DNA-tracking company agreeing to pay a settlement worth $30 million. The ...

A bankruptcy judge approved the sale of genetics company 23andMe to a non-profit led by co-founder and former CEO Anne Wojcicki, according to a June 27 filing in the bankruptcy docket. TTAM Research ...

Pharmaceutical maker Regeneron announced Monday it will buy genetic testing company 23andMe for $256 million following a bankruptcy auction. Regeneron said it will acquire 23andMe’s genomics service ...

Regeneron Pharmaceuticals, a company that has been analyzing genetic data as part of its drug research for more than a decade, is augmenting its capabilities in a big way with the $256 million ...

New York Attorney General Letitia James argued 23andMe "cannot auction 15 million customers’ highly sensitive personal genetic information without their consent or knowledge." 23andMe says the lawsuit ...

The sale of 23andMe was finalized this week, following the company filing for bankruptcy in March. The sale was previously approved by a judge. The company was purchased by the nonprofit TTAM Research ...